These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 33709512)
1. Editorial for "Noninvasive Assessment of MGMT Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space Occupancy Combined with Structural MR Imaging". Politi LS; Pessina F; Simonelli M; Navarria P J Magn Reson Imaging; 2021 Jul; 54(1):237-238. PubMed ID: 33709512 [No Abstract] [Full Text] [Related]
2. Noninvasive Assessment of O(6)-Methylguanine-DNA Methyltransferase Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space-Occupancy Combined with Structural Magnetic Resonance Imaging. He W; Li X; Hua J; Liao S; Guo L; Xiao X; Liu X; Zhou J; Wang W; Xu Y; Wu Y J Magn Reson Imaging; 2021 Jul; 54(1):227-236. PubMed ID: 33590929 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Radiomics Analyses Based on Different Magnetic Resonance Imaging Sequences in Grading and Molecular Genomic Typing of Glioma. Huang WY; Wen LH; Wu G; Hu MZ; Zhang CC; Chen F; Zhao JN J Comput Assist Tomogr; 2021 Jan-Feb 01; 45(1):110-120. PubMed ID: 33475317 [TBL] [Abstract][Full Text] [Related]
5. Editorial for "Apparent Diffusion Coefficient as Imaging Biomarker for Identifying IDH Mutation, 1p19q Codeletion, and MGMT Promoter Methylation Status in Patients With Glioma". Salihoğlu AK; Booth TC J Magn Reson Imaging; 2023 Sep; 58(3):739-740. PubMed ID: 36594487 [No Abstract] [Full Text] [Related]
6. Kong Z; Lin Y; Jiang C; Li L; Liu Z; Wang Y; Dai C; Liu D; Qin X; Wang Y; Liu Z; Cheng X; Tian J; Ma W Cancer Imaging; 2019 Aug; 19(1):58. PubMed ID: 31426864 [TBL] [Abstract][Full Text] [Related]
7. Quality assessment of the MRI-radiomics studies for MGMT promoter methylation prediction in glioma: a systematic review and meta-analysis. Doniselli FM; Pascuzzo R; Mazzi F; Padelli F; Moscatelli M; Akinci D'Antonoli T; Cuocolo R; Aquino D; Cuccarini V; Sconfienza LM Eur Radiol; 2024 Sep; 34(9):5802-5815. PubMed ID: 38308012 [TBL] [Abstract][Full Text] [Related]
8. The association between Okita Y; Shofuda T; Kanematsu D; Yoshioka E; Kodama Y; Mano M; Kinoshita M; Nonaka M; Fujinaka T; Kanemura Y Clin Radiol; 2020 Aug; 75(8):622-628. PubMed ID: 32321646 [TBL] [Abstract][Full Text] [Related]
9. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas. Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441 [TBL] [Abstract][Full Text] [Related]
10. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors. Bady P; Delorenzi M; Hegi ME J Mol Diagn; 2016 May; 18(3):350-361. PubMed ID: 26927331 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive impact of MGMT promoter methylation in grade 3 gliomas. Haque W; Thong E; Andrabi S; Verma V; Brian Butler E; Teh BS J Clin Neurosci; 2021 Mar; 85():115-121. PubMed ID: 33581781 [TBL] [Abstract][Full Text] [Related]
14. Histogram analysis of 11C-methionine integrated PET/MRI may facilitate to determine the O6-methylguanylmethyltransferase methylation status in gliomas. Yu P; Ning J; Xu B; Liu J; Dang H; Lin M; Feng X; Grimm R; Tian J Nucl Med Commun; 2019 Aug; 40(8):850-856. PubMed ID: 31135693 [TBL] [Abstract][Full Text] [Related]
15. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients. Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093 [TBL] [Abstract][Full Text] [Related]
16. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas. Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598 [TBL] [Abstract][Full Text] [Related]
17. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival. Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998 [TBL] [Abstract][Full Text] [Related]
18. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication. Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219 [TBL] [Abstract][Full Text] [Related]
19. Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation. Yoon RG; Kim HS; Paik W; Shim WH; Kim SJ; Kim JH Eur Radiol; 2017 Jan; 27(1):255-266. PubMed ID: 27048531 [TBL] [Abstract][Full Text] [Related]
20. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas. Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]